BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Science in Boston - ECPv6.18.3.1//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Science in Boston
X-ORIGINAL-URL:https://scienceinboston.com
X-WR-CALDESC:Events for Science in Boston
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/New_York
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20180311T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20181104T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20190310T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20191103T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20200308T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20201101T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20191018T183000
DTEND;TZID=America/New_York:20191018T200000
DTSTAMP:20190909T151629Z
CREATED:20190909T151629Z
LAST-MODIFIED:20190909T151629Z
UID:6454-1571423400-1571428800@scienceinboston.com
SUMMARY:ETH Meets Boston 2019
DESCRIPTION:Description\nRETHINK Drug Discovery\nRecent advances in chemical synthesis\, biological testing\, and artificial intelligence (AI) allow for greater automation in the drug discovery process. AI systems that generate novel design suppositions\, as well as\, cope with multiple design objectives provide a basis for further automation in some aspects of drug discovery. Automation could potentially accelerate timeframes for compound design and optimization. It could also enable better decision making in early-stage pharmaceutical discovery that translates into late-stage clinical validation. However\, such approaches also raise considerable conceptual\, technical\, and organizational challenges. \nThis symposium aims to address the latest advances of this rapidly progressing field of science\, by bringing together leading researchers to present the state-of-the-art in drug discovery. Together they will make daring predictions surrounding the possibilities and limitations of drug discovery using machine intelligence. \nProgramme and further information
URL:https://scienceinboston.com/event/eth-meets-boston-2019/
LOCATION:District Hall Boston\, 75 Northern Avenue\, Boston\, MA\, 02210\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20191018T183000
DTEND;TZID=America/New_York:20191018T200000
DTSTAMP:20190909T151629Z
CREATED:20190909T151629Z
LAST-MODIFIED:20190909T151629Z
UID:27339-1571423400-1571428800@scienceinboston.com
SUMMARY:ETH Meets Boston 2019
DESCRIPTION:Description\nRETHINK Drug Discovery\nRecent advances in chemical synthesis\, biological testing\, and artificial intelligence (AI) allow for greater automation in the drug discovery process. AI systems that generate novel design suppositions\, as well as\, cope with multiple design objectives provide a basis for further automation in some aspects of drug discovery. Automation could potentially accelerate timeframes for compound design and optimization. It could also enable better decision making in early-stage pharmaceutical discovery that translates into late-stage clinical validation. However\, such approaches also raise considerable conceptual\, technical\, and organizational challenges. \nThis symposium aims to address the latest advances of this rapidly progressing field of science\, by bringing together leading researchers to present the state-of-the-art in drug discovery. Together they will make daring predictions surrounding the possibilities and limitations of drug discovery using machine intelligence. \nProgramme and further information
URL:https://scienceinboston.com/event/eth-meets-boston-2019-2/
LOCATION:District Hall Boston\, 75 Northern Avenue\, Boston\, MA\, 02210\, United States
END:VEVENT
END:VCALENDAR